Martin C. Garnett
- Biomaterials top 0.2%
- Molecular Biology top 5%
- Biomedical Engineering top 2%
- Pharmaceutical Science top 0.1%
- Organic Chemistry top 2%
- Co-authors
- Snow StolnikLisbeth IllumParaskevi KallinteriPaul GellertMartyn C. DaviesCameron AlexanderVincenzo TarescoDriton Vllasaliu
- Topics
- Nanoparticle-Based Drug Delivery (28 papers)Monoclonal and Polyclonal Antibodies Research (24 papers)RNA Interference and Gene Delivery (21 papers)
- Partner nations
- United KingdomItalyThailand
In The Last Decade
Martin C. Garnett
129 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Biomaterials 2.6k
- Molecular Biology 2.2k
- Biomedical Engineering 1.3k
- Pharmaceutical Science 1.3k
- Organic Chemistry 1.2k
Countries citing papers authored by Martin C. Garnett
This map shows the geographic impact of Martin C. Garnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin C. Garnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin C. Garnett more than expected).
Fields of papers citing papers by Martin C. Garnett
This network shows the impact of papers produced by Martin C. Garnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin C. Garnett. The network helps show where Martin C. Garnett may publish in the future.
Co-authorship network of co-authors of Martin C. Garnett
This figure shows the co-authorship network connecting the top 25 collaborators of Martin C. Garnett. A scholar is included among the top collaborators of Martin C. Garnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin C. Garnett. Martin C. Garnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 29 | |
| 3 | 19 | |
| 4 | 48 | |
| 5 | 53 | |
| 6 | 35 | |
| 7 | 63 | |
| 8 | 16 | |
| 9 | 76 | |
| 10 | 52 | |
| 11 | 22 | |
| 12 | 9 | |
| 13 | 13 | |
| 14 | 39 | |
| 15 | 116 | |
| 16 | 120 | |
| 17 | 51 | |
| 18 | 1 | |
| 19 | 242 | |
| 20 | 12 |
About Martin C. Garnett
Martin C. Garnett is a scholar working on Pharmaceutical Science, Biomaterials and Surfaces, Coatings and Films, having authored 131 papers that have together received 6.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (28 papers), Monoclonal and Polyclonal Antibodies Research (24 papers) and RNA Interference and Gene Delivery (21 papers). The work is most often cited by research in Pharmaceutical Science (1.3k citations), Biomaterials (2.6k citations) and Surfaces, Coatings and Films (481 citations). Martin C. Garnett has collaborated with scholars based in United Kingdom, Italy and Thailand. Frequent co-authors include Snow Stolnik, Lisbeth Illum, Paraskevi Kallinteri, Paul Gellert, Martyn C. Davies, Cameron Alexander, Vincenzo Taresco, Driton Vllasaliu, C. R. Heald and S.S. Davis. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.